BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25907971)

  • 1. Frequency and distribution of Notch mutations in tumor cell lines.
    Mutvei AP; Fredlund E; Lendahl U
    BMC Cancer; 2015 Apr; 15():311. PubMed ID: 25907971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
    Wang K; Zhang Q; Li D; Ching K; Zhang C; Zheng X; Ozeck M; Shi S; Li X; Wang H; Rejto P; Christensen J; Olson P
    Clin Cancer Res; 2015 Mar; 21(6):1487-96. PubMed ID: 25564152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.
    Cama A; Verginelli F; Lotti LV; Napolitano F; Morgano A; D'Orazio A; Vacca M; Perconti S; Pepe F; Romani F; Vitullo F; di Lella F; Visone R; Mannelli M; Neumann HP; Raiconi G; Paties C; Moschetta A; Tagliaferri R; Veronese A; Sanna M; Mariani-Costantini R
    Acta Neuropathol; 2013 Oct; 126(4):575-94. PubMed ID: 23955600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy.
    Egloff AM; Grandis JR
    Clin Cancer Res; 2012 Oct; 18(19):5188-95. PubMed ID: 22773520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
    O'Neil J; Grim J; Strack P; Rao S; Tibbitts D; Winter C; Hardwick J; Welcker M; Meijerink JP; Pieters R; Draetta G; Sears R; Clurman BE; Look AT
    J Exp Med; 2007 Aug; 204(8):1813-24. PubMed ID: 17646409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
    Lee SH; Jeong EG; Yoo NJ; Lee SH
    APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma.
    Cheng C; Cui H; Zhang L; Jia Z; Song B; Wang F; Li Y; Liu J; Kong P; Shi R; Bi Y; Yang B; Wang J; Zhao Z; Zhang Y; Hu X; Yang J; He C; Zhao Z; Wang J; Xi Y; Xu E; Li G; Guo S; Chen Y; Yang X; Chen X; Liang J; Guo J; Cheng X; Wang C; Zhan Q; Cui Y
    Gigascience; 2016; 5():1. PubMed ID: 26759717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer.
    Mullendore ME; Koorstra JB; Li YM; Offerhaus GJ; Fan X; Henderson CM; Matsui W; Eberhart CG; Maitra A; Feldmann G
    Clin Cancer Res; 2009 Apr; 15(7):2291-301. PubMed ID: 19258443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making sense out of missense mutations: Mechanistic dissection of Notch receptors through structure-function studies in Drosophila.
    Yamamoto S
    Dev Growth Differ; 2020 Jan; 62(1):15-34. PubMed ID: 31943162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into Autoregulation of Notch3 from Structural and Functional Studies of Its Negative Regulatory Region.
    Xu X; Choi SH; Hu T; Tiyanont K; Habets R; Groot AJ; Vooijs M; Aster JC; Chopra R; Fryer C; Blacklow SC
    Structure; 2015 Jul; 23(7):1227-35. PubMed ID: 26051713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis.
    Luiken S; Fraas A; Bieg M; Sugiyanto R; Goeppert B; Singer S; Ploeger C; Warsow G; Marquardt JU; Sticht C; De La Torre C; Pusch S; Mehrabi A; Gretz N; Schlesner M; Eils R; Schirmacher P; Longerich T; Roessler S
    Oncogene; 2020 Apr; 39(15):3128-3144. PubMed ID: 32055024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canonical Notch signalling is inactive in urothelial carcinoma.
    Greife A; Jankowiak S; Steinbring J; Nikpour P; Niegisch G; Hoffmann MJ; Schulz WA
    BMC Cancer; 2014 Aug; 14():628. PubMed ID: 25167871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Notch signaling inhibitor NSI‑1 suppresses nuclear translocation of the Notch intracellular domain.
    Shiraishi T; Sakaitani M; Otsuguro S; Maenaka K; Suzuki T; Nakaya T
    Int J Mol Med; 2019 Oct; 44(4):1574-1584. PubMed ID: 31364722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Notch Signaling in the Tumor Microenvironment.
    D'Assoro AB; Leon-Ferre R; Braune EB; Lendahl U
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
    Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
    Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Notch signaling pathway gene mutations as a prognostic biomarker for bladder cancer.
    Xue C; Chen X; Lin K; Tong Y; Wang X
    Future Oncol; 2021 Nov; 17(32):4307-4320. PubMed ID: 34338007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.
    Lobry C; Oh P; Aifantis I
    J Exp Med; 2011 Sep; 208(10):1931-5. PubMed ID: 21948802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.
    Aste-Amézaga M; Zhang N; Lineberger JE; Arnold BA; Toner TJ; Gu M; Huang L; Vitelli S; Vo KT; Haytko P; Zhao JZ; Baleydier F; L'Heureux S; Wang H; Gordon WR; Thoryk E; Andrawes MB; Tiyanont K; Stegmaier K; Roti G; Ross KN; Franlin LL; Wang H; Wang F; Chastain M; Bett AJ; Audoly LP; Aster JC; Blacklow SC; Huber HE
    PLoS One; 2010 Feb; 5(2):e9094. PubMed ID: 20161710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch pathway activation induces neuroblastoma tumor cell growth arrest.
    Zage PE; Nolo R; Fang W; Stewart J; Garcia-Manero G; Zweidler-McKay PA
    Pediatr Blood Cancer; 2012 May; 58(5):682-9. PubMed ID: 21744479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.